alpha fetoprotein levels [lbtr]    
Interferon Therapy [topp]    
Regression [patf]    
Fibrosis, Liver [dsyn]    
Patients [podg]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Aims [idcn]    
chronic Hepatitis C virus infection [dsyn]    
Improves [qlco]    
Fibrosis, Liver [dsyn]    
HEPATOCELLULAR CARCINOMA [neop]    
Chronic Hepatitis C virus [dsyn]    
Patients [podg]    
Evaluated [hlca]    
Relationship [qlco]    
FIBROSIS [patf]    
Regression [patf]    
Assessed [acty]    
Sequential [idcn]    
Biopsies [diap]    
Patients [podg]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Methods [inpr]    
Patients [podg]    
Men [popg]    
Chronic Hepatitis C virus [dsyn]    
Treated [ftcn]    
therapy [ftcn]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Evaluate [hlca]    
Fibrosis stage [clna]    
TIME [tmco]    
Patients [podg]    
Pre-Therapy [tmco]    
Initial [tmco]    
BIOPSY [diap]    
Second [qnco]    
BIOPSY [diap]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
TIME [tmco]    
Biopsies [diap]    
Fibrosis stage [clna]    
involuting [qlco]    
Patients [podg]    
STABLE [qlco]    
progressed [ftcn]    
4 - 6 [qnco]    
Fibrosis stage [clna]    
Decreased [qnco]    
UNITS [qnco]    
UNITS [qnco]    
Levels [qlco]    
End [spco]    
treatment [ftcn]    
LOWER [spco]    
Platelet Count [lbpr]    
End [spco]    
treatment [ftcn]    
Significantly high [qnco]    
Patients [podg]    
FIBROSIS [patf]    
Regression [patf]    
logistic regression analysis [resa]    
confirmed [qlco]    
LOWER [spco]    
Levels [qlco]    
End [spco]    
treatment [ftcn]    
Odds Ratio [qnco]    
Hepatitis C virus genotype 2 [virs]    
Odds Ratio [qnco]    
786-0 [emod]    
Independent [idcn]    
predictive factor [inpr]    
involuting [qlco]    
FIBROSIS [patf]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Conclusions [idcn]    
LOWER [spco]    
post treatment [tmco]    
Levels [qlco]    
Hepatitis C virus genotype 2 [virs]    
Correlated [qlco]    
Fibrosis, Liver [dsyn]    
Regression [patf]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
